Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is ...

DEERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16 ...

Baxter International Inc. closed 29.99% short of its 52-week high of $44.01, which the company reached on March 8th.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Baxter International Inc. (NYSE: BAX) has recently announced significant changes to its executive leadership and provided an update on its financial outlook through an 8-K filing with the Securities ...

Baxter International’s longtime CEO and board chair, José Almeida, is stepping down and retiring, effective immediately, the ...

Baxter International Inc. (BAX), a healthcare company, Monday announced the appointment of Lead Independent Director Brent Shafer as ...

Deerfield: Baxter International Inc., has announced that José (Joe) E. Almeida, chair, president and chief executive officer ...